Excerpts from RHB report

Analyst: Jarick Seet

Profit Margins Continue To Improve; BUY
Maintain BUY and DCF-based TP of SGD0.30, 20% upside and c.7% yield. As at 9M20, Fu Yu Corp had SGD97.8m net cash with zero borrowings, despite COVID-19 affecting production.

FU YU

Share price: 
25 c

Target: 
30 c

With further streamlining of its operations in China, despite lower revenue due to the closing of its Chongqing factory, we expect further cost savings ahead.

9M20 GPM also expanded to 23.5% from 18.0% in 9M19.

We expect the company to tide through the pandemic with attractive yields.



9M20 PATMI surged 36.7% YoY despite a 23.4% drop in revenue, mainly due the higher GPM. This can be attributed mainly to the change in revenue mix, a reduction in headcount, as well as the group’s ongoing initiatives to sustain costs and raise operational efficiencies.

FuYu machine1.20Fu Yu produces parts for products in various industries. Photo: CompanyGPM continued to improve to 23.5% from 18.0% a year ago.

With challenging business conditions expected ahead, management will continue to evaluate avenues to further rightsize and optimise its manufacturing operations in China to ensure it is better positioned for long-term business sustainability, ie by closing its Chongqing factory, which will likely provide further cost savings operationally.

Strong net cash; Attractive yield. As at 1H20, Fu Yu had a strong net cash position of SGD97.8m and zero borrowings.

It has also maintained an interim dividend payout.

We expect a 1.7 SG cents payout for FY20F, which should result in an attractive yield of 6.5%.

With management learning from past mistakes during the manufacturing crisis, its prudent approach has led to the company having a net cash balance sheet representing close to 53% of its market cap.

Coupled with its rich cash flow generation, we believe that it will be able to weather this storm, and come out stronger than its competitors.

Still one of our Top Picks; Stable and resilient. With further new projects in the medical and consumer and automotive fronts, we expect positive growth momentum for 4Q20F.

JarickSeet3.18Jarick Seet, analystDespite a blip in FY20F caused by the pandemic, we believe that Fu Yu – with its strong net cash balance sheet – will able to weather the storm, and at the same time, reward investors with attractive dividends going forward, despite a temporary drop in FY20F profits.

As a result, we maintain BUY and our DCF-based SGD0.30 TP.

The company is also an attractive target for privatisation or acquisition.

Key risks to our call: Economic slowdown, worsening trade war, and increasing COVID-19 cases.


Full report here. 


Share Prices

Counter NameLastChange
AEM Holdings3.510-0.090
Avarga0.250-
Avi-Tech Electronics0.420-0.005
Best World Int.1.360-
CEI0.9700.010
China Sunsine0.510-0.005
CNMC GoldMine0.2800.010
CSE Global0.465-
Food Empire0.590-0.005
Golden Energy0.153-0.002
GSS Energy0.0570.001
ISDN Holdings0.410-0.010
ISOTeam0.1470.002
IX Biopharma0.245-
JB Foods0.5600.005
KSH Holdings0.335-0.005
Medtecs Intl0.955-0.065
Moya Asia0.070-
Nordic Group0.2600.020
Oxley Holdings0.220-0.010
Procurri0.310-
REX International0.145-0.006
Riverstone1.280-0.030
Roxy-Pacific0.355-
SingMedical0.255-
Sri Trang Agro1.140-0.020
Straco Corp.0.585-
Sunningdale Tech1.520-
Sunpower Group0.7300.030
The Trendlines0.090-0.001
UG Healthcare0.655-0.025
Uni-Asia Group0.6350.025
Yangzijiang Shipbldg0.910-0.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 1895 guests and one member online

  • josephyeo